Latest investment
Jan 04 2017
No. of Startups
countries invested
funding size
Latest investment date
Latest investment name
No. of startups
No of rounds
No of Co investors
Avg No of co-investors per round


HQ address
Acme Plaza, Mumbai, 400 059, IND
An international speciality pharma company, with a large presence in the US and India, Sun Pharma has a footprint across 40 other markets.

In the US, which is the group's largest market, Sun Pharma has built a strong pipeline of generics, directly and through its subsidiaries Caraco and Sun Pharmaceutical Inc. Taro adds strong dermatology range to this portfolio.

In India and rest of the world markets, Sun Pharma's brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology etc. We are market leaders in speciality therapy areas in India.

Sun Pharma began as a startup with just five psychiatry brands in 1983. In the time since, we’ve crossed several milestones to emerge as one of the leading pharma companies in India, and one of the largest Indian companies in the US generic market. In India we’re the largest speciality prescription company and ranked 6th. In the US, it offers a comprehensive portfolio of generics including controlled substances and dermatologicals.

The organization retains the drive for growth that marked its early days, when it had begun in 1983 with just 5 products. Since then, it has crossed several milestones to emerge as a leading pharma company in India where it is the 6th largest by prescription sales, a rank that has been retained over a decade. (IMS ORG Stockist Audit, Sept. 2010)

Since the mid-nineties, Sun Pharma has used a combination of growth and acquisition to drive growth. important acquisitions have included those of the US, detroit-based Caraco Parma Labs and a plant at Halol which now holds UKMHRA and USFDA approvals. The 2010 acquisition of Taro Pharmaceuticals doubles the organization's US business and brings in strengths in dermatology and pediatrics.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats